Benefits of Tirzepatide besides weight loss Besides significant weight loss, Tirzepatide helps improve blood sugar control, insulin sensitivity, and cardiovascular health
About SELECT clinical study SELECT (Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity) is a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of semaglutide 2.4 mg versus placebo as an adjunct to standard of care for the prevention of major adverse cardiac events (MACE) in people with overweight or obesity and established cardiovascular disease with no prior history of diabetes
While short-term imaging rarely shows dramatic bone density change, longer-term studies may reveal subtle shifts
In the meantime, you may notice other changes , like fewer cravings, better control over your eating, and an increased sense of fullness after you eat
Highly recommend to anyone looking for this
This product is intended solely for laboratory research use